Medicine

Opportunities as well as challenges for patient-reported end result evaluation in multimorbidity research and also method

.Completing interests.S.E.H. obtains funding from the National Institute of Health as well as Care R...

Hibernation science utilized to manage obesity and tweak metabolism

.Attribute Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizin...

CAR- T and mobile genetics treatments are also expensive

.Nature Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care...

The that genomics program of work for nondiscriminatory execution of human genomics for worldwide wellness

.The publication of the initial draft of the individual genome pattern in 20011 was actually complie...

A time-stratified, case\u00e2 $ \"crossover study of warmth visibility as well as perinatal mortality from 16 medical facilities in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in four sub-Saharan African nations, our company...

Advancing worldwide antibiotic research, advancement and gain access to #.\n\nMurray, C. J. L. et cetera. International burden of microbial antimicrobial protection in 2019: a step-by-step evaluation. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of particular dedications as well as activity in the action to antimicrobial resistance. Global Frontrunners Group on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Wellness Organization. That publishes checklist of microorganisms for which brand new anti-biotics are urgently required. Planet Health Association https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Planet Health Company. That microbial priority virus checklist, 2024: microbial pathogens of hygienics importance to help investigation, growth and strategies to avoid as well as manage antimicrobial resistance. World Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative access. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nGlobe Health Institution. 2023 anti-bacterial brokers in scientific and also preclinical development: a summary and evaluation. World Health Institution https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Testimonial. May 19, 2016 \u00e2 $\" Addressing drug-resistant infections globally: final file and suggestions. Customer Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outcomes: reports and also instruction. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall: an ask for collective action on antibiotics research and development. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Concise 51: Exactly how can the EU assistance sustainable advancement and also access to successful anti-biotics? plan alternatives for existing as well as brand new medicines. International Observatory on Wellness Equipments and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic use and also resistance\u00e2 $\" verifying the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health And Wellness Association. 2021 Conscious distinction. That get access to, watch, reserve, classification of antibiotics for examination as well as tracking of use. World Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Center for Condition Prevention and Command. Antimicrobial protection targets: just how can our team reach all of them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health And Wellness Institution. Lack of technology set to undermine antibiotic performance and also wellness gains. Globe Health and wellness Association https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. Just how antimicrobial protection is linked to temperature improvement: a summary of pair of linked international challenges. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial contaminations: our team need to have immediate action and assets that focus on the weakest web link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health Organization. Booster shot insurance coverage. Globe Health Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease prevention as well as control in low-resource settings: the requirement for the neighborhood, the contextual as well as the practical. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of executing antimicrobial conservation devices in low to mid income nations (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A brief record of the antibiotic age: sessions discovered and problems for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Client gain access to in 14 high-income countries to new antibacterials permitted due to the United States Food and Drug Administration, European Medicines Company, Japanese Pharmaceuticals and Medical Tools Company, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health And Wellness Association. 2021 anti-bacterial agents in clinical as well as preclinical progression: an introduction and study. Planet Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the business economics must assist the scientific research. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of development in antibacterial rehabs. Medical Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Assessing medical professional usage of next-generation prescription antibiotics versus resisting Gram-negative diseases in U.S. healthcare facilities: a retrospective mate research study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in anti-bacterial therapies. Medical Development Association https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. An organized customer review and also vital evaluation of incentive methods for revelation and also growth of unique anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth And Wellness Unexpected Emergency Readiness and also Feedback Authority. Trial and error of health care countermeasures. International Compensation https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Payment. Pre-draft proposition for an European relationship under Perspective Europe One Wellness Antimicrobial Protection. European Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Antibiotic Research and Development Partnership. Entasis Therapies and the Worldwide Antibiotic Research &amp Advancement Relationship to create a brand new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of sector- as well as non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health Company. Variety of clinical test enrollments through site, condition, period of progression, grow older and also sexual activity of trial participants (1999\u00e2 $ \"2022). World Health Institution https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Prescription Antibiotic Experimentation Relationship. NeoSept1: a study to calculate the ranking of existing as well as brand-new prescription antibiotics mixtures to alleviate newborn babies that remain in medical facility with serious blood poisoning. ISRCTN pc registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Government of Canada makes significant investment to combat antimicrobial resistance (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Antibiotic Trial And Error Collaboration. Japan government backing supports GARDP\u00e2 $ s initiatives to resist antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Groundwork. Novo Nordisk Groundwork partners with CARB-X to overcome drug-resistant contaminations. novo nordisk foundation https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health as well as Digital Executive Agency. Study on delivering AMR health care countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Determining the ideal size of international pull rewards for antibacterial medications. Wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry incentive for the growth of brand new antibiotics. Harvard Kennedy Institution https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Field incentives and also antibiotic protection: an intro to the antibiotic vulnerability bonus. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG progressed dedication for subscription-based acquiring of unfamiliar antimicrobials and its anticipated roi. Facility for Global Development https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 expenditures in new prescription antibiotics will settle \u00e2 $\" for everybody. Workplace of Wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts fight versus lethal diseases adhering to productive world-first aviator. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Process of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Payment. Reform of the EU pharmaceutical legalisation. International Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Repayment models to tackle market breakdowns for antimicrobials: techniques absorbed France, Germany, Sweden, the UK, and also the United States. Health Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Alliance of Drug Manufacturers and also Organizations. From resistance to durability: what could the potential antibiotic pipeline resemble? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Hub &amp World Wellness Company. Incentivising the growth of brand new anti-bacterial procedures: 2023 progress report due to the Worldwide AMR R&ampD Hub and WHO. Worldwide AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Performer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK membership design for prescription antibiotics looked at successful? Lancet Germ 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimuli for the advancement and keeping on the market of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, as well as national root causes of little one mortality in 2000\u00e2 $ \"thirteen, along with projections to update post-2015 priorities: an improved organized evaluation. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et al. Anti-bacterial medication lacks coming from 2001 to 2013: implications for professional practice. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage body for medication lacks: explanation as well as styles coming from 2012 to 2018: an empirical retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et al. Analysis of that antibiotic usage and access intendeds in 76 nations, 2000\u00e2 $ \"15: an evaluation of pharmaceutical sales data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Dealing with the phonies: dealing with second-rate as well as falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving easier to get prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nAfrican Society for Lab Medication. Policy concise as well as infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic intake for individual usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Medication. Affect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial intake: study of main warehouses materials to in-patient care health and wellness centers coming from 2017 to 2019 in Uganda. Trop. Medication. Affect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Variants in the usage of antimicrobial medications in the European region, 2014\u00e2 $ \"2018: results and ramifications from ESAC-Net as well as WHO Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et cetera. Medication lack: triggers, effect, and also minimization methods. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Individual accessibility in 14 high-income nations to brand-new antibacterials accepted by the US Fda, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Instruments Organization, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et cetera. Forgotten prescription antibiotics: a follow-up stock study in Europe, the United States, Canada and Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness advancement for worldwide wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Business Partnership. The 2023 AMR Field Alliance development survey: production and the setting. amr Sector Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can health care products be developed on a charitable manner? Exploring product advancement alliances for overlooked health conditions. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et al. Restart biomedical R&ampD in the worldwide public rate of interest. Attributes 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Disease Management as well as Protection. Africa CDC spearheads daring relocate to protect Africa\u00e2 $ s wellness future by developing a fifty billion buck medical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Haggling public-health copyright licensing arrangements to enhance accessibility to health innovations: an insider\u00e2 $ s tale. BMJ Chunk. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New organization versions for trial and error with affordability criteria are actually required to achieve fair costs of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Accelerator. Stewardship as well as gain access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Prescription Antibiotic Experimentation Relationship. Shinogi, GARDP and also CHAI declare site certificate as well as partnership arrangements to handle bacterial diseases next to extending accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Industry Partnership. Leaving the laboratory: tracking the decline in AMR R&ampD specialists. amr Industry Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 contact us to action on antimicrobial protection. G7G20 Documentations Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Worldwide Union on Getting Older &amp Contagious Illness Culture of United States. 2024 AMR readiness mark progress report. Evaluating government activity on AMR plan. Worldwide Union on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food as well as Horticulture Institution of the United Nations, United Nations Environment Program, World Wellness Company &amp. Globe Organisation for Creature Wellness. Worldwide data bank for tracking antimicrobial protection (AMR): country self-assessment poll (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the wid...

Integrating liver endpoints in scientific tests of heart as well as kidney illness

.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of vi...

FALSE:: INACCURACY: UNSUPPORTED ENCODING...

Artificial intelligence assisted screening process for cardiomyopathies in an obstetric population: a practical randomized scientific test

.Trial style and oversightThe Screening for PEripartum Cardiomyopathies along with Artificial Intell...

Sustained HIV remission after allogeneic hematopoietic stalk tissue transplant along with wild-type CCR5 contributor tissues

.Attributes Medicine, Published online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remissi...